- Advertise
- Contact Editorial
- Editorial Submission Guidelines
- Contact MJH Life Sciences
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Roshawn Blunt, Brand Insights Contributor, Managing Director of 1798, a Fingerpaint company
Articles
Price Transparency: Does the Pharmaceutical Industry Need to Prepare Today for the Implications of Price Transparency on Commercialization and Market Access?
Brand Insights - Thought Leadership | Paid Program
Patient Support Design is Critical for Cell and Gene Therapies
Brand Insights - Thought Leadership from Marketers I Paid Program
Why it’s important to integrate patient assistance programs for cell and gene therapies into the overall clinical development plan.
Solving Access Challenges in Today’s Market
Brand Insights - Thought Leadership from Marketers I Paid Program
New drug launches face more marketplace scrutiny today than a decade ago. Brand success requires not only communicating the clinical value to providers and patients, but also demonstrating the cost-effectiveness to payers in a real-world setting.